欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 爱思唯尔研究者学院:从初稿到接收 全程赋能 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | BREAST CANCER RESEARCH BREAST CANCER RES (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.3
51人评分
我要评分
声誉 8.3 影响力 6.6 速度 7.1 | |||||||||||||||||||||
期刊ISSN | 1465-5411 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||
E-ISSN | 1465-542X | |||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 5.6 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:5.597 | |||||||||||||||||||||
2024-2025自引率 | 1.80%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 7 | |||||||||||||||||||||
JCI期刊引文指标 | 1.3 | |||||||||||||||||||||
h-index | 132 | |||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | http://breast-cancer-research.biomedcentral.com | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/brcr/ | |||||||||||||||||||||
作者指南网址 | http://breast-cancer-research.biomedcentral.com/submission-guidelines | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足BREAST CANCER RESEARCH的语言要求,还能让BREAST CANCER RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被BREAST CANCER RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( GBP2890; USD3990; EUR3290; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:oncology、breast cancer 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||
出版商 | BioMed Central | |||||||||||||||||||||
涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Bimonthly | |||||||||||||||||||||
出版年份 | 1999 | |||||||||||||||||||||
年文章数 | 186点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 100.00% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 97.31% | |||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1465-5411%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 12 Weeks | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 容易 | |||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( GBP2890; USD3990; EUR3290; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在BREAST CANCER RESEARCH顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Exploratory multi-cohort, multi-reader study on the clinical utility of a deep learning model for transforming cryosectioned to formalin-fixed, paraffin-embedded (FFPE) images in breast lesion diagnosis Author: Chao, Xue; Wu, Yu; Cai, Xi; He, Jiehua; Zheng, Chengyou; Li, Mei; Luo, Rongzhen; Song, Lijuan; Li, Xiaoqin; Feng, Wentai; Xu, Shuoyu; Sun, Peng Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02064-z PubMed DOI |
2. | Discovery and validation of cell-free DNA methylation markers for specific diagnosis, differentiation from benign tumors, and prognosis of breast cancer Author: Gao, Lijing; Zhang, Lei; Liu, Jinyin; Wang, Liwan; Fu, Qingzhen; Liu, Siyu; Li, Yanbing; Qu, Chao; Zhao, Ning; Tan, Shiheng; Fang, Fang; Tian, Tian; Jiang, Shi; Wu, Junxiao; Dong, Yan; Gong, Yajie; Cao, Yukun; Wang, Fan; Zhang, Xianyu; Pang, Da; Zhao, Yashuang Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02066-x PubMed DOI |
3. | Optimizing breast lesions diagnosis and decision-making with a deep learning fusion model integrating ultrasound and mammography: a dual-center retrospective study (vol 27, 80, 2025) Author: Xu, Ziting; Zhong, Shengzhou; Gao, Yang; Huo, Jiekun; Xu, Weimin; Huang, Weijun; Huang, Xiaomei; Zhang, Chifa; Zhou, Jianqiao; Dan, Qing; Li, Lian; Jiang, Zhouyue; Lang, Ting; Xu, Shuying; Lu, Jiayin; Wen, Ge; Zhang, Yu; Li, Yingjia Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02060-3 PubMed DOI |
4. | Wearable device for axillary lymph node screening in breast cancer based on infrared thermography and artificial intelligence Author: Zhong, Xiaoying; Deng, Jinqiu; Lu, Ping; Zuo, Zhichao; Zhao, Yu; Zhou, Yidong; Wang, Xuefei Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02027-4 PubMed DOI |
5. | Dissecting the tumor microenvironment in primary breast angiosarcoma: insights from single-cell RNA sequencing Author: Ding, Peikai; Pei, Shengbin; Zhai, Yi; Qu, Zheng; Yang, Yazhe; Feng, Xiaolong; Liu, Qiang; Wang, Xiangyu; Zhang, Wenxiang; Wang, Zhongzhao; Kong, Xiangyi; Wang, Jing; Fang, Yi Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02022-9 PubMed DOI |
6. | SENP5 drives breast cancer progression through deSUMOYlation of CDK1 Author: Chen, Cui; Yao, Hanming; Jie, Haiqing; Liang, Zhenkang; Zhang, Yuxuan; Wen, Xinyun; Zhao, Jinze; Xiong, Huiping; Zheng, Zongheng; Wu, Juekun Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02054-1 PubMed DOI |
7. | Advances in CTC and ctDNA detection techniques: opportunities for improving breast cancer care Author: Zhong, Hai-Jing; Zhen, Yumiao; Chen, Shiji; Shi, Wei; Liang, Xiaoxu; Yang, Guan-Jun Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02024-7 PubMed DOI |
8. | Sialylated IgG expressed in triple-negative breast cancer cells promotes cancer progression by promoting glycolysis Author: Hu, Chenyang; Zhang, Shenghua; Duan, Fugang; Huang, Xinmei; Huang, Jing; Zhu, Zhu; Mo, Xiaoning; Xu, Weiyan; Wu, Lina; Fan, Zhimin; Qiu, Xiaoyan Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02052-3 PubMed DOI |
9. | Investigating the mechanism of inositol against paclitaxel chemoresistance on triple-negative breast cancer by using 7T multiparametric MRI and mitochondrial changes Author: Xuan, Wentao; Li, Wangmin; Ke, Lixin; Shen, Yuanyu; Zhang, Xiaolei; Chen, Yue; Ye, Zhiliang; Zhuang, Caiyu; Xie, Shiyan; Wu, Renhua; Lin, Yan Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02051-4 PubMed DOI |
10. | NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors Author: Gao, Ying; Zuo, Lin; Zheng, Yu; Sun, Keyan; Gao, Yunhui; Xu, Xiaobo; Li, Zengqiang; Zuo, Daiying Journal: BREAST CANCER RESEARCH. 2025; Vol. 27, Issue 1, pp. -. DOI: 10.1186/s13058-025-02045-2 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室